Showing 9401-9410 of 20873 results for "".
Artificial Intelligence in Dermatology: Exploring New Diagnostic Strategies
https://reachmd.com/programs/clinicians-roundtable/artificial-intelligence-in-dermatology-exploring-new-diagnostic-strategies/32382/Explore how artificial intelligence can support dermatologists by aiding in skin lesion classification and detecting malignancies.Preventing Alzheimer’s Disease Through Lifestyle Interventions
https://reachmd.com/programs/neurofrontiers/preventing-alzheimers-disease-through-lifestyle-interventions/29097/Here are the lifestyle interventions that could reduce the risk of Alzheimer's disease by up to 45 percent.ISDPA: Dr. Bhatia and Dr. Zirwas Discuss the Itchy Patient
https://reachmd.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-bhatia-and-dr-zirwas-discuss-itchy-patient/27065/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, talks with Matthew Zirwas, MD, about Dr. Zirwas’s lecture on the itchy patient and the latest solutions for itch at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.The Impact of Advocacy on Healthcare
https://reachmd.com/programs/project-oncology/the-impact-of-advocacy-on-healthcare/24502/Why is advocacy important to the healthcare field? Tune in.Early Combination Therapy in IgA Nephropathy
https://reachmd.com/programs/frontlines-iga-nephropathy/early-combination-therapy-iga-nephropathy/60617/Earlier intervention is changing the treatment paradigm for patients with IgA nephropathy who are at high risk of disease progression. But how should clinicians identify and care for patients who may benefit from simultaneous kidney-protective and immune-targeted therapies? Find out with Dr. Gates CAdvancing Bone Health: Key Insights from ISO 2026
https://reachmd.com/programs/boning-up-on-osteoporosis/bone-health-iso-2026/61159/From fracture liaison services to menopause care, the 2026 Interdisciplinary Symposium on Osteoporosis (ISO) covered the latest advances and interdisciplinary strategies in bone health. Join Marshall Miller and Ami Patel, Vice President of Science and Education at the Bone Health and Osteoporosis FoManaging RVO: Goals of Early Intervention
https://reachmd.com/programs/eye-on-ocular-health/managing-rvo-goals-of-early-intervention/54487/Retinal vein occlusion (RVO) can lead to significant vision loss when macular edema and ischemic complications are not recognized and treated early. Hear Dr. Michael Javaheri discuss the burden of RVO, key treatment goals, and how newer anti-VEGF therapies may help improve durability while reducingBoosting Colorectal Cancer Screening in Rural Clinics: Insights from SMARTER CRC
https://reachmd.com/programs/clinicians-roundtable/boosting-colorectal-cancer-screening-in-rural-clinics-insights-from-smarter-crc/36409/The SMARTER CRC trial evaluated mailed fecal immunochemical (FIT) outreach and patient navigation strategies across rural clinics, analyzing how implementation factors like clinic-sent letters, consistent FIT usage, and active participation in health plan meetings impacted screening outcomes. Two auObesity and Asthma: Intersecting Pathways and Real-World Impacts
https://reachmd.com/programs/clinicians-roundtable/obesity-asthma-poor-disease-control/54181/Emerging evidence highlights a complex, bidirectional relationship between obesity and asthma, driven by shared genetics, epigenetic influences, environmental exposures, and metabolic dysfunction. Learn more with Dr. Anne Dixon, who’s a pulmonologist, professor, and the E. L. Amidon Chair of the DepBehind the Breakout: Acne as a Meaningful Side Effect of JAK Inhibitors for IBD
https://reachmd.com/programs/Audioabstracts/jak-inhibitors-acne-side-effect-ibd/49088/As JAK inhibitors become more widely used in treating inflammatory bowel disease (IBD), a new challenge is emerging: acne. That’s why Ryan Quigley spotlights the largest international cohort study to date examining JAK inhibitor-associated acne across more than 2,000 patients. Tune in to learn how f